Nanocellulose-collagen-apatite composite associated with OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) for bone regeneration
-
Add time:08/31/2019 Source:sciencedirect.com
Despite advances in the field of biomaterials for bone repair/regeneration, some challenges for developing an ideal bone substitute need to be overcome. Herein, this study synthesized and evaluated in vitro a nanocomposite based on bacterial cellulose (BC), collagen (COL), apatite (Ap) and OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) (OGP) or its C-terminal pentapeptide [OGP(10-14)] for bone regeneration purposes. The BC-COL nanocomposites were successfully obtained by carbodiimide-mediated coupling as demonstrated by spectroscopy analysis. SEM, FTIR and 31P NMR analyses revealed that in situ synthesis to apatite was an effective route for obtaining of bone-like apatite. The OGP-containing (BC-COL)-Ap stimulated the early development of the osteoblastic phenotype. Additionally, the association among collagen, apatite, and OGP peptides enhanced cell growth compared with OGP-containing BC-Ap. Furthermore, none of the nanocomposites showed cytotoxic, genotoxic or mutagenic effects. These promising results suggest that the (BC-COL)-Ap associated with OGP peptides might be considered a potential candidate for bone tissue engineering applications.
We also recommend Trading Suppliers and Manufacturers of OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3). Pls Click Website Link as below: cas 132996-61-3 suppliers
Prev:Surface modification of TiO2 nanotubes with OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) to enhance osteoblast differentiation
Next:OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) promotes osteogenic differentiation of mesenchymal stem cells mediated by LncRNA AK141205-induced upregulation of CXCL13) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Peptide TQS169 prevents osteoporosis in rats by enhancing osteogenic differentiation and calcium absorption09/07/2019
- Resorbable, amino acid-based poly(ester urea)s crosslinked with OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) with enhanced mechanical properties and bioactivity09/06/2019
- Nanostructured materials based on mesoporous silica and mesoporous silica/apatite as OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) carriers09/05/2019
- Novel OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) C-terminal pentapeptide grafted poly(d,l-lactic acid) improves the proliferation and differentiation of osteoblasts: The potential bone regenerative biomaterial09/04/2019
- Fibroin/peptide co-functionalized calcium titanate nanorods improve osteoinductivity of titanium via mimicking osteogenic niche09/03/2019
- Characterization and in vitro biological evaluation of mineral/OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) nanocomposites synthesized biomimetically on titanium09/02/2019
- OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) promotes osteogenic differentiation of mesenchymal stem cells mediated by LncRNA AK141205-induced upregulation of CXCL1309/01/2019
- Surface modification of TiO2 nanotubes with OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) to enhance osteoblast differentiation08/30/2019
- Three-dimensional printing and in vitro evaluation of poly(3-hydroxybutyrate) scaffolds functionalized with OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) for tissue engineering08/29/2019


